![](/img/cover-not-exists.png)
Addition of PSMA ADC to enzalutamide therapy significantly improves survival in in vivo model of castration resistant prostate cancer
DiPippo, Vincent A., Nguyen, Holly M., Brown, Lisha G., Olson, William C., Vessella, Robert L., Corey, EvaVolume:
76
Language:
english
Journal:
The Prostate
DOI:
10.1002/pros.23124
Date:
February, 2016
File:
PDF, 1.02 MB
english, 2016